Census Bureau: Marginal increases in retail sales for July
WASHINGTON The Census Bureau announced Friday that advance estimates of retail and food services sales for July totaled $362.7 billion, an increase of 0.4% from the previous month, and 5.5% above July 2009.
For the month, retail trade sales were up 0.4% from June, and 5.9% above last year. Grocery store sales slightly dropped in July from nearly $43.32 million to $42.23 million. While advance estimates for pharmacies and drug stores sales were not available, sales for the month of June totaled $18.7 million, up almost 1.1% from May.
Total sales for the May through July 2010 period were up 5.9% from the same period a year ago.
Periscope introduces Flip Cover+Lights
RIDGEWOOD, N.J. Periscope has introduced an integrated reading light and deluxe cover for e-readers.
Periscope’s Flip Cover+Lights is available in two versions — one that’s compatible with both the Amazon Kindle 2 (6-inch screen) and Barnes & Noble Nook e-readers and a second larger version that is compatible with the Amazon Kindle DX e-reader.
The new Flip Cover+Lights are available at the following suggested retail prices: $49.95 for the Kindle 2/Nook version and $59.95 for the larger Kindle DX version.
“As the market for e-readers grows and expands at an explosive rate, so too does the demand for e-reader covers and reading lights,” said Periscope president Eric Fisherman. “Covers and lights are essential components of the e-reader package and neither is included with a basic e-reader purchase. What’s more, all current e-readers are standardized on a screen technology that is not back lit, which makes the purchase of a reading light mandatory if the product is to be enjoyed in a low light environment.”
Pfizer’s Xyntha-administering syringe gets FDA approval
NEW YORK The Food and Drug Administration has approved a prefilled dual-chamber syringe made by Pfizer for treating hemophilia, Pfizer said.
The FDA approved the syringe for administering the drug Xyntha (antihemophilic factor [recombinant]) for hemophilia A. The drug is used to prevent and control bleeding episodes in patients.
“The approval of the pre-filled dual-chamber syringe is an important milestone for hemophilia patients due to its innovative, convenient reconstitution system that eliminates the transfer step,” Pfizer VP marketing for specialty biologics Emil Andrusko said.